Get the Stockscreener App
0.905
1.62%
-0.0149
After Hours:
.90
-0.005
-0.55%
Quince Therapeutics Inc stock is currently priced at $0.905, with a 24-hour trading volume of 227.28K.
It has seen a -1.62% decreased in the last 24 hours and a -9.50% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.9166 pivot point. If it approaches the $0.9033 support level, significant changes may occur.
Previous Close:
$0.9199
Open:
$0.91
24h Volume:
227.28K
Market Cap:
$39.11M
Revenue:
-
Net Income/Loss:
$-31.39M
P/E Ratio:
-1.0904
EPS:
-0.83
Net Cash Flow:
$-18.45M
1W Performance:
-4.74%
1M Performance:
-9.50%
6M Performance:
+5.23%
1Y Performance:
-43.08%
1D Range:
$0.90
$0.97
52W Range:
$0.84
$1.74
Quince Therapeutics Inc Stock (QNCX) Company Profile
Name
Quince Therapeutics Inc
Sector
Industry
Phone
415 910 5717
Address
601 Gateway Blvd, Ste 1250, South San Francisco
Quince Therapeutics Inc Stock (QNCX) Latest News
Quince Therapeutics Inc [QNCX] Investment Guide: What You Need to Know – Knox Daily - Knox Daily
Knox Daily
Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results - Business Wire
Business Wire
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference - Yahoo Canada Finance
Yahoo Canada Finance
Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results - Business Wire
Business Wire
The Zacks Analyst Blog Highlights Quince Therapeutics and XBiotech
Zacks Investment Research
Don't Know Much Biology? Tips for Picking Microcap Biotech, Pharma
Zacks Investment Research
Quince Therapeutics Inc Stock (QNCX) Financials Data
Quince Therapeutics Inc (QNCX) Net Income 2024
QNCX net income (TTM) was -$31.39 million for the quarter ending December 31, 2023, a +39.25% increase year-over-year.
Quince Therapeutics Inc (QNCX) Cash Flow 2024
QNCX recorded a free cash flow (TTM) of -$18.45 million for the quarter ending December 31, 2023, a +58.23% increase year-over-year.
Quince Therapeutics Inc (QNCX) Earnings per Share 2024
QNCX earnings per share (TTM) was -$0.84 for the quarter ending December 31, 2023, a +46.84% growth year-over-year.
About Quince Therapeutics Inc
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
0.77%
1.20%
Cap:
|
Volume (24h):